Journals / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 1

Chromosomal findings and sequence analysis of target exons of calcium-sensing receptor (CaSR) gene in patients with Sagliker syndrome

Pages
13–21
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our data suggest that there may be a correlation between CAs and the progression of SS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Sagliker syndrome (SS) develops as a continuation of chronic kidney disease and secondary hyperparathyroidism conditions.
📊
Key Findings & Data:We aimed to examine SS patients for chromosome aberrations (CAs) and CaSR gene abnormalities in exons 2 and 3.
💡
Conclusion & Impact:Our data suggest that there may be a correlation between CAs and the progression of SS.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Sagliker syndrome (SS) develops as a continuation of chronic kidney disease and secondary hyperparathyroidism conditions. It was thought that there are some genetic predisposition factors leading to SS. The calcium-sensing receptor (CaSR) is essential for calcium homeostasis in the body. We aimed to examine SS patients for chromosome aberrations (CAs) and CaSR gene abnormalities in exons 2 and 3. Materials and methods: Twenty-three patients and 23 control subjects were admitted to Balcalı Hospital of the Medical Faculty of Çukurova University in Turkey between 2009 and 2011. Chromosomal analysis was performed according to standard cytogenetic methods. Full sequencing of exons 2 and 3 of the CaSR gene was done. Results: We found base alterations and deletions in exons 2 and 3 of the CaSR gene. We also found a statistically significant increase in the rate of CAs in patients compared to controls. In total we evaluated 639 metaphase plaques in 23 patients and found 241 CAs, of which 88% were structural and 12% were numerical abnormalities. Conclusion: There is no relation between the etiology of SS and nucleotide alterations that we could find in exons 2 and 3 of the CaSR gene. Our data suggest that there may be a correlation between CAs and the progression of SS.

🔖

Cite This Article

DEMİRHAN, O., GÜZEL, A. İ., PAYLAR, N., TUNÇ, E., YILDIZ, İ., SAĞLIKER, Y. (2022). Chromosomal findings and sequence analysis of target exons of calcium-sensing receptor (CaSR) gene in patients with Sagliker syndrome. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 1, 13–21. https://ajindex.com/articles/610484

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Sagliker Y, Balal M, Sagliker Ozkaynak P, Paydas S, Sagliker C, Sabit Sagliker H, Kiralp N, Mumin Adam S, Tuncer I, Gonlusen G et al. Sagliker syndrome: uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure. Semin Nephrol 2004; 24: 449-455
  2. Sagliker Y, Acharya V, Ling Z, Golea O, Sabry A, Eyupoglu K, Ookalkar DS, Tapiawala S, Durugkar S, Khetan P et al. International study on Sagliker syndrome and uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic kidney disease patients. J Ren Nutr 2008; 18: 114-117
  3. Giray S, Sagliker Y, Yildiz I, Halvaci I, Paylar N, Ocal F, Balal M, Ozkaynak PS, Paydas S, Sagliker C et al. Neurologic manifestations in Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients. J Ren Nutr 2006; 16: 233-236
  4. Erkan AN, Sagliker Y, Yildiz I, Ozluoglu L. Audiological findings in chronic kidney disease patients with Sagliker syndrome. J Ren Nutr 2010; 20: S56-58
  5. Ozenli Y, Giray S, Sagliker Y, Adam SM. A controlled study of psychiatric manifestations and electroencephalography findings in chronic kidney disease patients with Sagliker syndrome. J Ren Nutr 2010; 20: S51-55
  6. Uzel A, Uzel I, Sagliker Y, Yildiz I, Halvaci I, Paylar N, Ocal F, Balal M, Ozkaynak PS, Paydas S et al. Cephalometric evaluation of patients with Sagliker Syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients. J Renal Nutr 2006; 16: 229-232
  7. Sagliker Y, Acharya V, Golea O, Sabry A, Bali M, Eyupoglu K, Ookalkar D, Tapiawala S, Durugkar S, Khetan P et al. Is survival enough for quality of life in Sagliker Syndrome-uglifying human face appearance in chronic kidney disease? J Nephrol 2008; 21: S134-138
  8. Zhang L, Yao I, Bian WJ, Li WG, Chen YP. Prognosis of Sagliker Syndrome after PTX in hemodialysis patients with severe secondary hyperparathyroidism. Nephrology 2008; 13: A57
  9. Bakır S, Yıldız I, Sağlıker Y. Evaluation of hearing function in patients with Sağlıker Syndrome. Dicle Tıp Dergisi 2009; 36: 195- 199 (in Turkish with English abstract)
  10. Yavascan O, Bal A, Anil M, Kuyum P, Aksu N. Sagliker Syndrome in a pediatric patients. Abstr Perit Dial Int 2010; 30: 25
  11. Grzegorzewska AE, Kaczmarek-Leki V. A case of severe longterm secondary hyperparathyroidism (Sagliker Syndrome) in a patient treated with intermitte